Development

Eli Lilly's triple agonist delivers 28.7% weight loss

development2025-12-15

Claim

Eli Lilly's triple agonist produced 28.7% weight loss in Phase 3 trials.

Reported metric: 28.7%

Reporting date: 2025-12-15 (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Welcome to December 15, 2025 (theinnermostloop.substack.com)

Knowledge graphopen in browser →

Reported in

Welcome to December 15, 2025

Actor

Eli Lilly

Referenced by

Welcome to December 15, 2025

Cite or correct this record

Citation formatCitation text

Eli Lilly's triple agonist delivers 28.7% weight loss
Innermost Loop KB — secondary record
Reporting date: 2025-12-15
KB permalink: https://nicholsn.github.io/innermost-loop-kb/developments/2025-12-15-lilly-triple-agonist-28-7
Claim: Eli Lilly's triple agonist produced 28.7% weight loss in Phase 3 trials.
Attributed sources:
- Welcome to December 15, 2025 — https://theinnermostloop.substack.com/p/welcome-to-december-15-2025
This citation does not imply independent verification of linked-source claims.

Suggest a correction — opens a GitHub draft for you to review and submit.